Novartis
Bookmark
ShareNovartis is a company. It is in Basel, Switzerland and its CEO is Vasant Narasimhan. It was founded in 1996 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Basel
- country: Switzerland
- employees: 108,000 people
- revenues: 52.8B $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1996
- CEO: Vasant Narasimhan
- CEO approval: 63 %
- ESG score: Try Pro to see estimate
- environmental score (ESG): Try Pro to see estimate
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more facts
Extract data
Download datasets about Novartis:
Dataset of stocks from Novartis:
Novartis is one of the companies in Pharmaceuticals, companies in Health Care, companies in Basel, companies in Switzerland and 3,456,835 companies in our database.
Talking Points
- Working together, we can reimagine medicine to improve and extend people’s lives.
- Our purpose is to reimagine medicine to improve and extend people’s lives. See our community guidelines: https://t.co/8fvS5jsThu
- Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and ...
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
- ノバルティス
- Novartis Germany
- Welcome to the Novartis Deutschland GmbH website. Novartis Germany is a global group with strong patient and customer focus. We focus on innovative, prescription medication and generics.
- Our purpose is to Reimagine Medicine to Improve and Extend People’s Lives. See Our Community Guidelines: https://t.co/8fvs5jsthu
- Novartis Germany Pharmaceutical Manufacturing We Think Medicine New to improve and extend people's lives.
- In Austria too, Novartis has a long company tradition-the Kundl site is 75 years old: The success story of Novartis in Austria goes back to 1946 when a former brewery was converted into a penicillin factory. Because penicillin and beer are based on the same procedure: fermentation. In Austria, Novartis has a long company tradition - the Kundl site is 75 years old: Die
- We think of medicine new to improve and extend people's lives. | We think medicine new Novartis and their generic division Sandoz with around 5,000 employees in Vienna and Tyrol are among the leading pharmaceutical companies in Austria. In our Tyrolean works in Kundl and Schaftenau we do research and produce ...
- Novartis Pakistan
- Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- 저장
- 한국노바티스: 우리의 사명은 인류의 생명을 연장하고 삶을 개선하기 위해 치료제의 정의를 새롭게 세우는 것입니다. 한국노바티스: 우리의 사명은 인류의 생명을 연장하고 삶을 개선하기 위해 치료제의 정의를 새롭게 세우는 것입니다.
- ... ... Novartis Korea Limited
- Home
- In Novartis we transform medicine by a global pharmaceutical company that operates in 140 countries and employs approximately 110,000 people. Our mission is to discover new solutions that improve and extend the life of patients. In the Czech Republic we bring therapy in the field of cardiology, neurology, ophthalmology, respiration and oncology.
- OUR PURPOSS IS TO REIMAGINE MEDICINE TO IMPROVE AND EXTEND PEOPLE’S LIVES. See Our Community Guidelines: https://t.co/8fvs5jsthu
- We are a global pharmaceutical society that operates in 140 countries and employs approximately 110,000 people. We rank among the world's leading companies that invest in their own research and development. Our mission is to discover new solutions that improve and extend the life of patients.
- Novartis Brasil
- Novartis is a global healthcare company based in switzerland that provides solutions to address the evolving needs of cats worldwide. Novartis today concentrates their efforts on innovation for non -met patients around the world. Novartis Brazil and their precursor companies have a past of over 250 years, with a rich history in the development of innovative products.
- Novartis United Kingdom
- Novartis Austria
- Novartis Austria - At Novartis we think of medicine. We want to find new ways to help people get a better and longer life.
- Homepage
- Our goal is to redefine medical practice, to improve and expand people's lives. As a leading world pharmaceutical company, we use innovative scientific data and digital technologies for the development of innovative therapies that make the difference in areas where there is a great deal of medical. Our goal is to redefine medical practice to improve and expand
- Our purpose is to reimagine medicine to improve and extend people's lives. See Our Community Guidelines: https://t.co/8fvs5jsthu
- Novartis France
- In Novartis, we reinvent medicine to improve and prolong the lives of patients.
- Novartis Switzerland
- Novartis is a global pharmaceutical company with its headquarters in Switzerland. We develop innovative medication and therapies in order to meet the ever further developed needs of patients worldwide.
- Novartis Finland
- Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to
- Kehitämme uusia tapoja pidentää ja parantaa elämää. Yhteisöohjeet: https://t.co/NsDpnfIeAd Tietosuoja: https://t.co/ruIZKU9OXr
- Novartis United States of America
- Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. At Novartis, we reimagine medicine in the broadest possible sense, from finding innovative treatments that improve and extend people’s lives, to making our healthcare system more accessible and equitable for all. We put special emphasis on developing sustainable solutions that address the root causes of healthcare disparities and inequities, using new tools, approaches and perspectives to drive meaningful change.
- Explore stories about how Novartis innovation has impacted people worldwide.
- Contacts
- Whether you are a customer, job seeker, health or media professional, or an investor, find relevant contact information at Novartis for your specific inquiry.
- With the acquisition of The Medicines Company by Novartis completed, this page is no longer active. | With the acquisition of The Medicines Company by Novartis completed, this page is no longer active. Thank you to our followers and keep in touch by following Novartis.
- About | Novartis
- Reimagining medicine by transforming cancer | At Novartis, our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
- Research and development | Novartis
- Our people With more than 6000 scientists, physicians and business professionals around the world, we have an ...
- Novartis Pharma Switzerland puts more than 100 drugs subject to prescription in various therapeutic fields, such as for example neurology, immunology, dermatology as well as cardiology, respiratory diseases and oncology.
- Yesterday Twitter Das Team Social Von Novartis Schweiz 👩🔬❤ Weitere Info: https://t.co/chqio425K1
- Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with “lazy eye”
- Technology has potential to reimagine treatment for amblyopia (“lazy eye”), a leading cause of vision loss in children and young adults1Acquisition expands the Novartis refractive disorder pipeline in ophthalmology Basel, April 20, 2020 — Novartis announced today that it has completed the acquisition of Amblyotech, a US-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the
- The official account for @Novartis News & Media Updates. For media inquiries: media.relations@novartis.com. See our community guidelines: https://t.co/b4Kyh4V3CU
- Novartis builds on commitment to addressing need in neuropsychiatric disorders with Cadent Therapeutics acquisition
